# US Medical Oxygen Concentrators Market

> US Medical Oxygen Concentrators Market Research Report: Size, Share, Trend Analysis By End Users (Hospitals and Clinics, Homecare Settings, Others) By Indication (Chronic Obstructive Pulmonary Disease (COPD), Asthma, Sleep Apnea, Others) By Technology (Continuous Flow, Pulse Dose) By Product Type (Portable Oxygen Concentrators, Stationary Oxygen Concentrators) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.26%
- **2024:** $ 879.55 Million
- **2025:** $ 934.61 Million
- **2035:** $ 1,715.61 Million
- **Key Players:** Philips (NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (NO), Caire Inc. (US)

**Report ID:** MRFR/MED/16531-CR · **Pages:** 100 · **Author:** Rahul Gotadki & Garvit Vyas · **Last Updated:** January 29, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-medical-oxygen-concentrators-market-18059

---

## Market Summary

## **US Medical Oxygen Concentrators Market Highlighted Trends & Dynamics**

The US Medical Oxygen Concentrators market has witnessed a significant surge in demand, driven by various factors such as an aging population, increasing prevalence of respiratory diseases, and the ongoing COVID-19 pandemic.

**COVID-19 Impact:** The pandemic has underscored the crucial role of oxygen concentrators in managing respiratory distress, leading to a heightened awareness and adoption of these devices among both healthcare providers and individuals.

**Aging Population:** With a rapidly aging population, there is an upswing in the number of individuals suffering from chronic respiratory conditions, creating a sustained demand for medical oxygen concentrators as a primary treatment option.

**Home Healthcare Trend:** A notable shift towards home healthcare has been observed, with patients preferring the comfort and convenience of receiving medical oxygen therapy in the familiar environment of their homes. This trend has further fueled the demand for portable and reliable oxygen concentrators.

**Technological Advancements:** The market is experiencing continuous innovation in terms of technology, with manufacturers focusing on developing lightweight, user-friendly, and energy-efficient oxygen concentrators. These advancements enhance patient compliance and contribute to the overall market growth.

**Government Initiatives:** Government initiatives and healthcare policies promoting the accessibility of medical oxygen concentrators have played a pivotal role in expanding the market. These measures aim to ensure that patients, especially those in rural or underserved areas, have access to life-saving oxygen therapy.

**Rise in Respiratory Disorders:** The increasing prevalence of respiratory disorders, including chronic obstructive pulmonary disease (COPD) and asthma, has contributed significantly to the demand for medical oxygen concentrators. These devices provide a reliable source of supplemental oxygen for managing these chronic conditions.

**Awareness and Education:** Growing awareness about the benefits of oxygen therapy and the availability of medical oxygen concentrators has led to an increased acceptance among both healthcare professionals and the general public. This shift in perception has positively influenced market dynamics.

**Supply Chain Challenges:** Despite the rising demand, the market has faced challenges related to the supply chain, including disruptions in manufacturing and distribution during the pandemic. However, efforts are being made to streamline the supply chain to meet the growing needs of the market.

**Competitive Landscape:** The US Medical Oxygen Concentrators market is characterized by intense competition among key players. Companies are focusing on strategic collaborations, product launches, and mergers to strengthen their market presence and cater to the evolving needs of healthcare providers and patients.

**Regulatory Compliance:** Adherence to stringent regulatory standards and quality requirements is imperative in the medical devices sector. Companies operating in the market are investing in research and development to ensure their products comply with the latest regulatory guidelines.

**Future Prospects:**

 With the continuous advancements in technology, a growing aging population, and an increased focus on home healthcare, the US Medical Oxygen Concentrators market is poised for sustained growth. Manufacturers are likely to invest in research and development to stay ahead in this dynamic and evolving healthcare landscape.

## Market Drivers

### Supportive Government Policies and Funding

Supportive government policies and funding initiatives are driving the growth of the medical oxygen-concentrators market. The US government has implemented various programs aimed at improving access to healthcare, particularly for individuals with chronic illnesses. These initiatives often include financial assistance for purchasing medical equipment, including oxygen concentrators. Additionally, reimbursement policies for oxygen therapy are becoming more favorable, encouraging patients to invest in these devices. As a result, the medical oxygen-concentrators market is likely to benefit from increased accessibility and affordability, which may lead to a rise in the number of patients utilizing oxygen therapy.

### Rising Awareness of Oxygen Therapy Benefits

The medical oxygen-concentrators market is experiencing growth due to increasing awareness of the benefits of oxygen therapy among both healthcare professionals and patients. Educational initiatives and campaigns aimed at highlighting the importance of oxygen therapy in managing chronic respiratory conditions are gaining traction. This heightened awareness is leading to more patients seeking oxygen therapy as a viable treatment option. Furthermore, healthcare providers are becoming more proactive in recommending oxygen therapy, which is likely to boost the adoption of medical oxygen-concentrators. As the understanding of the therapeutic benefits of oxygen therapy expands, the market is expected to see a corresponding increase in demand for these devices.

### Shift Towards Home-Based Healthcare Solutions

The medical oxygen-concentrators market is benefiting from a significant shift towards home-based healthcare solutions. Patients are increasingly opting for home care due to its convenience and cost-effectiveness. The US healthcare system is evolving, with a focus on reducing hospital readmissions and promoting outpatient care. This trend is reflected in the growing sales of portable oxygen concentrators, which allow patients to maintain their mobility while receiving necessary oxygen therapy. The market for these devices is projected to grow, with estimates suggesting a compound annual growth rate (CAGR) of around 8% over the next few years. As more patients seek to manage their health conditions at home, the demand for medical oxygen-concentrators is expected to rise significantly.

### Increasing Prevalence of Respiratory Disorders

The medical oxygen-concentrators market is experiencing growth due to the increasing incidence of respiratory disorders such as chronic obstructive pulmonary disease (COPD) and asthma. According to the Centers for Disease Control and Prevention (CDC), approximately 16 million Americans are diagnosed with COPD, which necessitates the use of supplemental oxygen. This trend indicates a growing need for medical oxygen-concentrators, as they provide a reliable source of oxygen therapy for patients. Furthermore, the aging population in the US, which is more susceptible to respiratory ailments, is likely to contribute to the demand for these devices. As healthcare providers increasingly recognize the importance of oxygen therapy in managing chronic respiratory conditions, the medical oxygen-concentrators market is poised for significant expansion.

### Technological Innovations in Oxygen Concentrators

Technological innovations are playing a crucial role in shaping the medical oxygen-concentrators market. Manufacturers are increasingly investing in research and development to enhance the efficiency and portability of oxygen concentrators. Recent advancements include the development of lightweight, battery-operated models that provide patients with greater freedom and flexibility. Additionally, features such as smart connectivity and user-friendly interfaces are becoming more prevalent, making it easier for patients to monitor their oxygen levels. The introduction of these advanced devices is likely to attract a broader consumer base, thereby driving market growth. As technology continues to evolve, the medical oxygen-concentrators market is expected to witness a surge in demand for innovative solutions.

## Future Outlook

The [Medical Oxygen Concentrators Market](https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876) is projected to grow at a 6.26% CAGR from 2025 to 2035, driven by increasing respiratory diseases, aging population, and technological advancements.

**New opportunities:**

- Development of portable oxygen concentrators for home use Integration of telehealth services with oxygen therapy Expansion into underserved rural markets with mobile units

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand.

## Segment Insights

### By Product Type: Portable Oxygen Concentrators (Largest) vs. Stationary Oxygen Concentrators (Fastest-Growing)

In the US medical oxygen-concentrators market, Portable Oxygen Concentrators hold a significant share, driven by their convenience and mobility. With a growing preference for at-home care, these devices have become essential for patients who require ongoing oxygen therapy yet wish to maintain an active lifestyle. On the other hand, Stationary Oxygen Concentrators serve a different segment, catering mainly to patients who require constant oxygen supply at home, with a steady share in the market due to their reliability and performance.

Growth trends in this segment indicate a rising demand for portable solutions as telemedicine and home healthcare services expand. The increasing prevalence of chronic respiratory diseases and the aging population fuel this trend. Stationary units, while slower in growth, maintain a critical role due to their capacity and efficacy in delivering continuous oxygen, particularly for patients with severe conditions that necessitate high flow rates.

Portable Oxygen Concentrators (Dominant) vs. Stationary Oxygen Concentrators (Emerging)

Portable Oxygen Concentrators are regarded as the dominant segment within the US medical oxygen-concentrators market, offering unparalleled mobility and user-friendliness. These devices are designed for patients who require oxygen therapy while on the go, making them ideal for both daily activities and travel. They have become increasingly advanced, featuring lightweight designs, longer battery life, and user-friendly interfaces. Conversely, Stationary Oxygen Concentrators are emerging as a crucial alternative, particularly for individuals who need constant oxygen therapy at home. Although they lack the portability of their counterparts, they provide greater oxygen output and are typically more cost-effective for long-term use. Both segments cater to distinct user needs, ensuring that patients receive appropriate solutions based on their lifestyle and medical requirements.

### By Technology: Continuous Flow (Largest) vs. Pulse Dose (Fastest-Growing)

In the US medical oxygen-concentrators market, Continuous Flow technology dominates the landscape with a significant share, appealing to a broader segment of patients who require a consistent and reliable supply of oxygen. This segment's extensive use in hospitals and home-care settings has solidified its position, making it the preferred choice for many clinical applications.

On the other hand, Pulse Dose technology is increasingly gaining traction as the fastest-growing segment within the market. The rise in demand can be attributed to its efficiency and ease of use, particularly among active patients who require a portable solution that conserves oxygen while meeting their mobility needs. This shift in patient preferences is driving innovation and market expansion for Pulse Dose oxygen concentrators.

Technology: Continuous Flow (Dominant) vs. Pulse Dose (Emerging)

Continuous Flow technology is widely recognized for its reliability and consistent delivery of oxygen, catering primarily to patients with severe respiratory conditions who are in need of uninterrupted oxygen supply. It is predominantly utilized in medical settings and homes, providing stable support for patients requiring high flow rates. In contrast, Pulse Dose technology is emerging as a popular choice for those seeking mobility and flexibility. With the ability to deliver oxygen in pulses rather than a continuous stream, it offers significant advantages for active users, allowing them to engage in daily activities without the weight of larger devices. This dynamic gives Pulse Dose technology a significant edge in appealing to a new generation of users prioritizing convenience.

### By Indication: COPD (Largest) vs. Sleep Apnea (Fastest-Growing)

In the US medical oxygen-concentrators market, Chronic Obstructive Pulmonary Disease (COPD) represents the largest share among indications, due to the high prevalence of this condition among the aging population. This segment leads significantly, capturing the attention of manufacturers and healthcare providers alike, while asthma and 'others' follow as secondary segments. Sleep apnea, while smaller in comparison, has shown rapid growth, reflecting increasing awareness and diagnosis of the condition.

The growth of the indication segment is being driven by several factors including the rising incidence of respiratory diseases, an aging demographic, and advancements in technology that make oxygen therapy more accessible and effective. Innovations in portable oxygen concentrators are making treatments more convenient, catering to patients with COPD and sleep apnea. This trend is expected to continue, propelling both the COPD segment and the emerging sleep apnea segment further in the coming years.

COPD (Dominant) vs. Asthma (Emerging)

COPD has established itself as the dominant indication in the US medical oxygen-concentrators market, primarily driven by its widespread prevalence and serious health implications. Patients with COPD require reliable and efficient oxygen therapy to manage their symptoms effectively. In contrast, asthma is emerging as a significant segment due to growing awareness and diagnosis rates, particularly among younger populations. As treatment options evolve, the market is likely to see innovations tailored to asthma management. Both segments are integral to the market's dynamics, with COPD maintaining a robust lead while asthma carves out its space as a rising contender, appealing to manufacturers focused on specialized medical devices.

### By End User: Homecare Settings (Largest) vs. Hospitals and Clinics (Fastest-Growing)

The US medical oxygen-concentrators market exhibits a diverse distribution among its end user segments. Homecare settings currently hold the largest share, reflecting a growing demand for home-based healthcare solutions. This trend is driven by an increasing elderly population and a rise in chronic respiratory diseases, leading to higher adoption rates of portable oxygen solutions. In contrast, hospitals and clinics are experiencing rapid growth, attributed to the surge in hospitalization rates and advancements in medical technologies.

Growth trends in this segment are largely influenced by the shift towards outpatient care, enabling patients to receive treatment in home settings rather than institutional environments. Additionally, innovations in oxygen concentrator technology have made devices more accessible and affordable for homecare users. The increasing awareness of lifestyle-related health issues, alongside governmental initiatives promoting home healthcare services, further reinforces the momentum of these segments in the market.

Homecare Settings (Dominant) vs. Hospitals and Clinics (Emerging)

Homecare settings are the dominant end user segment for medical oxygen concentrators, driven by the convenience and flexibility these devices offer to patients needing oxygen therapy in their daily lives. The preference for in-home care is on the rise, influenced by an aging demographic and the prevalence of chronic respiratory illnesses. In contrast, hospitals and clinics represent an emerging segment, with significant investments in infrastructure and technology leading to enhanced patient care capabilities. This segment is characterized by a growing need for efficient oxygen delivery systems amid increasing patient admissions. The evolving healthcare landscape emphasizes the importance of both segments, as they cater to different patient needs while accelerating the adoption of oxygen concentrators.

## Competitive Benchmarking

The medical oxygen-concentrators market is characterized by a competitive landscape that is increasingly shaped by innovation, strategic partnerships, and a focus on enhancing patient care. Key players such as Philips (NL), Invacare (US), and OxyGo (US) are actively pursuing strategies that emphasize technological advancements and market expansion. Philips (NL) has positioned itself as a leader in the sector by investing heavily in research and development, particularly in portable oxygen solutions that cater to the growing demand for home healthcare. Meanwhile, Invacare (US) focuses on enhancing its product portfolio through strategic acquisitions and partnerships, thereby strengthening its market presence and operational capabilities. OxyGo (US) is also notable for its commitment to customer-centric innovations, which include user-friendly designs and improved mobility solutions, collectively shaping a competitive environment that prioritizes quality and accessibility. In terms of business tactics, companies are increasingly localizing manufacturing to reduce lead times and optimize supply chains. This approach appears to be a response to the need for greater efficiency and responsiveness in a moderately fragmented market. The competitive structure is influenced by the collective actions of these key players, who are leveraging their strengths to capture market share and enhance operational efficiencies. In October 2025, Philips (NL) announced the launch of a new line of portable oxygen concentrators designed specifically for active lifestyles. This strategic move is significant as it aligns with the growing trend of patients seeking mobility and independence in their treatment options. By focusing on portability, Philips (NL) not only addresses consumer needs but also reinforces its position as an innovator in the market. In September 2025, Invacare (US) completed the acquisition of a smaller competitor specializing in advanced oxygen delivery systems. This acquisition is indicative of Invacare's strategy to broaden its technological capabilities and enhance its product offerings. By integrating new technologies, Invacare (US) aims to improve patient outcomes and solidify its market position amidst increasing competition. In August 2025, OxyGo (US) entered into a strategic partnership with a telehealth provider to offer integrated solutions for remote patient monitoring. This collaboration is particularly relevant as it reflects the growing importance of digital health solutions in the medical oxygen-concentrators market. By combining oxygen therapy with telehealth services, OxyGo (US) is likely to enhance patient engagement and adherence to treatment protocols, thereby improving overall health outcomes. As of November 2025, the competitive trends in the medical oxygen-concentrators market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, as companies recognize the value of collaboration in driving innovation and expanding market reach. Looking ahead, competitive differentiation is expected to evolve from traditional price-based competition to a focus on technological innovation, enhanced patient experiences, and reliable supply chains. This shift underscores the necessity for companies to adapt and innovate continuously in order to maintain a competitive edge.

## Report Scope

| MARKET SIZE 2024 | 879.55(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 934.61(USD Million) |
| MARKET SIZE 2035 | 1715.61(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.26% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Philips (NL), Invacare (US), AirSep (US), OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (NO), Caire Inc. (US) |
| Segments Covered | Product Type, Technology, Indication, End User |
| Key Market Opportunities | Integration of advanced telehealth solutions enhances accessibility in the medical oxygen-concentrators market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the medical oxygen-concentrators market. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US medical oxygen-concentrators market?**
A: The market valuation was $879.55 Million in 2024.

**Q: What is the projected market size for the US medical oxygen-concentrators market by 2035?**
A: The market is projected to reach $1715.61 Million by 2035.

**Q: What is the expected CAGR for the US medical oxygen-concentrators market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.26% during the forecast period.

**Q: Which product type segment had the highest valuation in 2024?**
A: The stationary oxygen concentrators segment had a valuation of $615.73 Million in 2024.

**Q: What are the projected valuations for portable oxygen concentrators by 2035?**
A: The portable oxygen concentrators segment is projected to reach $515.12 Million by 2035.

**Q: Which technology segment is expected to show significant growth in the US medical oxygen-concentrators market?**
A: The continuous flow technology segment is expected to grow from $500.0 Million in 2024 to $1000.0 Million by 2035.

**Q: What is the market valuation for chronic obstructive pulmonary disease (COPD) indications in 2024?**
A: The valuation for COPD indications was $400.0 Million in 2024.

**Q: How do homecare settings compare to hospitals and clinics in terms of market valuation for oxygen concentrators?**
A: Homecare settings had a valuation of $450.0 Million in 2024, compared to $350.0 Million for hospitals and clinics.

**Q: Which key players are leading the US medical oxygen-concentrators market?**
A: Key players include Philips, Invacare, AirSep, OxyGo, Drive DeVilbiss Healthcare, Nidek Medical, GCE Group, and Caire Inc.

**Q: What is the projected valuation for asthma indications by 2035?**
A: The asthma indications segment is projected to reach $400.0 Million by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-medical-oxygen-concentrators-market-18059*